PD-1 monoclonal antibodies enhance the cryoablation-induced antitumor immune response: a breast cancer murine model research

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Zhou W, Yu M, Pan H, et al. Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer. J Immunother Cancer. 2021;9(4):e002343.
   PubMed Web of Science ®Google Scholar
• Brem RF. Radiofrequency ablation of breast cancer: a step forward. Radiology. 2018;289(2):325–326.
   PubMed Web of Science ®Google Scholar
• Spiliotis AE, Gäbelein G, Holländer S, et al. Microwave ablation compared with radiofrequency ablation for the treatment of liver cancer: a systematic review and meta-analysis. Radiol Oncol. 2021;55(3):247–258.
   PubMed Web of Science ®Google Scholar
• Ward RC, Lourenco AP, Mainiero MB. Ultrasound-Guided breast cancer cryoablation. AJR Am J Roentgenol. 2019;213(3):716–722.
   PubMed Web of Science ®Google Scholar
• Kwak K, Yu B, Lewandowski RJ, et al. Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation. Theranostics. 2022;12(5):2175–2204.
   PubMed Web of Science ®Google Scholar
• Dermani FK, Samadi P, Rahmani G, et al. PD-1/PD-L1 immune checkpoint: potential target for cancer therapy. J Cell Physiol. 2019;234(2):1313–1325.
   PubMed Web of Science ®Google Scholar
• Hosseini A, Gharibi T, Marofi F, et al. CTLA-4: from mechanism to autoimmune therapy. Int Immunopharmacol. 2020;80:106221.
   PubMed Web of Science ®Google Scholar
• Wu Q, Jiang L, Li SC, et al. Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway. Acta Pharmacol Sin. 2021;42(1):1–9.
   PubMed Web of Science ®Google Scholar
• Sun C, Mezzadra R, Schumacher TN. Regulation and function of the PD-L1 checkpoint. Immunity. 2018;48(3):434–452.
   PubMed Web of Science ®Google Scholar
• Benzon B, Glavaris SA, Simons BW, et al. Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer. Prostate Cancer Prostatic Dis. 2018;21(1):126–136.
   PubMed Web of Science ®Google Scholar
• Shi L, Chen L, Wu C, et al. PD-1 blockade boosts radiofrequency Ablation-Elicited adaptive immune responses against tumor. Clin Cancer Res. 2016;22(5):1173–1184.
   PubMed Web of Science ®Google Scholar
• Yakkala C, Chiang CL, Kandalaft L, et al. Cryoablation and immunotherapy: an enthralling synergy to confront the tumors. Front Immunol. 2019;10:2283.
   PubMed Web of Science ®Google Scholar
• Yakkala C, Denys A, Kandalaft L, et al. Cryoablation and immunotherapy of cancer. Curr Opin Biotechnol. 2020;65:60–64.
   PubMed Web of Science ®Google Scholar
• Katzman D, Wu S, Sterman DH. Immunological aspects of cryoablation of non-small cell lung cancer: a comprehensive review. J Thorac Oncol. 2018;13(5):624–635.
   PubMed Web of Science ®Google Scholar
• Sharma A, Kamal VK. Is cryoablation really safe and efficacious? Analyzing results from the SOLSTICE trial. J Thorac Oncol. 2021;16(1):e5.
   PubMed Web of Science ®Google Scholar
• Wu Y, Cao F, Zhou D, et al. Cryoablation reshapes the immune microenvironment in the distal tumor and enhances the anti-tumor immunity. Front Immunol. 2022;13:930461.
   PubMed Web of Science ®Google Scholar
• Llovet JM, De Baere T, Kulik L, et al. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18(5):293–313.
   PubMed Web of Science ®Google Scholar
• Arrigoni F, Bianchi G, Formiconi F, et al. CT-guided cryoablation for management of bone metastases: a single center experience and review of the literature. Radiol Med. 2022;127(2):199–205.
   PubMed Web of Science ®Google Scholar
• Budimir N, Thomas GD, Dolina JS, et al. Reversing T-cell exhaustion in cancer: lessons learned from PD-1/PD-L1 immune checkpoint blockade. Cancer Immunol Res. 2022;10(2):146–153.
   PubMed Web of Science ®Google Scholar
• Yi M, Zheng X, Niu M, et al. Combination strategies with PD-1/PD-L1 blockade: current advances and future directions. Mol Cancer. 2022;21(1):28.
   PubMed Web of Science ®Google Scholar
• Han Y, Liu D, Li L. PD-1/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020;10(3):727–742.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zheng J. Functions of immune checkpoint molecules beyond immune evasion. Adv Exp Med Biol. 2020;1248:201–226.
   PubMed Web of Science ®Google Scholar
• Xing R, Gao J, Cui Q, et al. Strategies to improve the antitumor effect of immunotherapy for hepatocellular carcinoma. Front Immunol. 2021;12:783236.
   PubMed Web of Science ®Google Scholar
• Zhu H, Du C, Yuan M, et al. PD-1/PD-L1 counterattack alliance: multiple strategies for treating triple-negative breast cancer. Drug Discov Today. 2020;25(9):1762–1771.
   PubMed Web of Science ®Google Scholar
• Rasihashemi SZ, Rezazadeh Gavgani E, Majidazar R, et al. Tumor-derived exosomal PD-L1 in progression of cancer and immunotherapy. J Cell Physiol. 2022;237(3):1648–1660.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xu L, Wang Y, et al. Antitumor immunity augmented by combining radiofrequency ablation with anti-CTLA-4 therapy in a subcutaneous murine hepatoma model. J Vasc Interv Radiol. 2020;31(7):1178–1186.
   PubMed Web of Science ®Google Scholar
• Huang S, Li T, Chen Y, et al. Microwave ablation combined with anti-PD-1 therapy enhances systemic antitumor immunity in a multitumor murine model of Hepa1-6. Int J Hyperthermia. 2022;39(1):278–286.
   PubMed Web of Science ®Google Scholar
• Zhu J, Yu M, Chen L, et al. Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: a pre-clinical study in a murine model. Diagn Interv Imaging. 2018;99(3):135–142.
   PubMed Web of Science ®Google Scholar
• Duan X, Wang M, Han X, et al. Combined use of microwave ablation and cell immunotherapy induces nonspecific immunity of hepatocellular carcinoma model mice. Cell Cycle. 2020;19(24):3595–3607.
   PubMed Web of Science ®Google Scholar
• Sengedorj A, Hader M, Heger L, et al. The effect of hyperthermia and radiotherapy sequence on cancer cell death and the immune phenotype of breast cancer cells. Cancers. 2022;14(9):2050.
   PubMed Web of Science ®Google Scholar
• Meng L, Zhang Z, Zhang X, et al. Case report: local cryoablation combined with pembrolizumab to eliminate lung metastases from ovarian clear cell carcinoma. Front Immunol. 2022;13:1006500.
   PubMed Web of Science ®Google Scholar
• Li M, Cui Y, Li X, et al. Functional changes of dendritic cells in C6 glioma-bearing rats that underwent combined argon-helium cryotherapy and IL-12 treatment. Technol Cancer Res Treat. 2016;15(4):618–624.
   PubMed Web of Science ®Google Scholar
• Gaitanis G, Bassukas ID. Immunocryosurgery for non-superficial basal cell carcinomas ≤ 20 mm in maximal diameter: five-year follow-up. J Geriatr Oncol. 2019;10(3):475–478.
   PubMed Web of Science ®Google Scholar
• Bu X, Yao Y, Li X. Immune checkpoint blockade in breast cancer therapy. Adv Exp Med Biol. 2017;1026:383–402.
   PubMed Web of Science ®Google Scholar
• Pellegrino B, Tommasi C, Cursio OE, et al. A review of immune checkpoint blockade in breast cancer. Semin Oncol. 2021;48(3):208–225.
   PubMed Web of Science ®Google Scholar